Role and evaluation of megakaryocytes and platelets in cardiovascular disease. A meeting perspective
- 1 February 1994
- journal article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 24 (2) , 100-104
- https://doi.org/10.1111/j.1365-2362.1994.tb00973.x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Big Platelets in Hyperlipidemic PatientsThe Journal of Clinical Pharmacology, 1992
- Effects of Hypoxia on Megakaryocyte Size and Number of C3H and BALB/c MiceExperimental Biology and Medicine, 1992
- Large Platelets Circulate in an Activated State in Diabetes MellitusSeminars in Thrombosis and Hemostasis, 1991
- Platelet function in Watanabe heritable hyperlipidemic rabbits. Decreased sensitivity to thromboxane A2.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- An analysis of megakaryocytopoiesis in the C3H mouse: an animal model whose megakaryocytes have 32N as the modal DNA classBlood, 1990
- Analysis of atherosclerosis susceptibility in mice with genetic defects in platelet function.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
- Increased platelet volume — Sign of impaired thrombopoiesis in diabetes mellitusJournal of Molecular Medicine, 1989
- Characterization of a genetic difference in the platelet aggregation response of two inbred mouse strains, C57BL/6 and C3H/HeAtherosclerosis, 1987
- Sex differences in mouse platelet aggregationThrombosis Research, 1986
- Variation in susceptibility to atherosclerosis among inbred strains of miceAtherosclerosis, 1985